Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Baricitinib drug shows significant success in treatment of rheumatoid arthritis

In a clinical phase-3-study, an international research cooperation of MedUni Vienna and Stanford University has achieved significant success with the drug Baricitinib for the treatment of rheumatoid arthritis. The test persons exhibited significantly less symptoms of the disorder. The results are now published in the top scientific journal "New England Journal of Medicine".

31 Mar 2016

BSR report outlines plans to help patients make informed choices about their treatment

A lack of national data and indicators in the UK makes it difficult for rheumatologists to demonstrate effective care for patients with inflammatory arthritis. This also leaves patients without the information they need to take control of their care.

31 Mar 2016

Researchers explore four potential treatments for Lyme disease

The ticks that transmit Lyme disease have multiplied aggressively over the past 20 years, and now thrive in half of all counties in the U.S., according to a recent study in the Journal of Medical Entomology.

30 Mar 2016

TSRI study shows hollowed-out version of CPMV could be effective in human therapies

Viruses aren't always bad. In fact, scientists can harness the capabilities of some viruses for good—modifying the viruses to carry drug molecules, for example.

29 Mar 2016

High out-of-pocket costs linked to lower use of specialty drugs

"Specialty drugs" have become important treatment options for many serious and chronic diseases, and in some conditions like cancer they represent the only chance for long-term survival.

29 Mar 2016

Oral administration of cyclotide may improve symptoms of multiple sclerosis

MedUni Vienna has made a crucial development in the treatment of Multiple Sclerosis (MS): Together with his team and the research group led by Gernot Schabbauer, international partners from Australia, Germany and Sweden, Christian Gruber, Chief Researcher at the Center for Physiology and Pharmacology has demonstrated in an animal model that, following treatment with a specially synthesized plant peptide (cyclotide), there is no further progression of the usual clinical signs of multiple sclerosis.

29 Mar 2016

Scientists identify two enzymes that appear to play role in metabolism, inflammation

A team led by scientists at The Scripps Research Institute and the Salk Institute for Biological Studies has discovered two enzymes that appear to play a role in metabolism and inflammation—and might someday be targeted with drugs to treat type 2 diabetes and inflammatory disorders.

29 Mar 2016

Novel way of hitting prostate cancer

Researchers at UC Davis, in collaboration with the other institutions, have found that suppressing the nuclear receptor protein ROR-γ with small-molecule compounds can reduce androgen receptor (AR) levels in castration-resistant prostate cancer and stop tumor growth.

29 Mar 2016

Engineered HIV vaccine protein may prevent HIV infection

Some people infected with HIV naturally produce antibodies that effectively neutralize many strains of the rapidly mutating virus, and scientists are working to develop a vaccine capable of inducing such "broadly neutralizing" antibodies that can prevent HIV infection.

28 Mar 2016

TSRI scientists develop new process to synthesize naturally occurring compound phorbol

In a landmark feat of chemical synthesis, scientists at The Scripps Research Institute have developed a 19-step process for making the naturally occurring compound phorbol in the laboratory, in quantities that are useful for pharmaceutical research.

24 Mar 2016

Cinqair (reslizumab) approved for treatment of severe asthma

The U.S. Food and Drug Administration today approved Cinqair (reslizumab) for use with other asthma medicines for the maintenance treatment of severe asthma in patients aged 18 years and older. Cinqair is approved for patients who have a history of severe asthma attacks (exacerbations) despite receiving their current asthma medicines.

23 Mar 2016

Researchers use DNA sequencing technology to identify gene variants that affect susceptibility to SLE

Demonstrating the potential of precision medicine, an international study based at UT Southwestern Medical Center used next-generation DNA sequencing technology to identify more than 1,000 gene variants that affect susceptibility to systemic lupus erythematosus (SLE).

21 Mar 2016

St. Luke’s surgeon first in world to implant Medtronic’s new, MRI-compatible neurostimulator system

Steven Falowski, MD, Chief of Functional Neurosurgery at St. Luke’s University Health Network in Bethlehem, Pennsylvania today was the first surgeon in the world to implant Medtronic’s brand new, full-body, MRI-compatible paddle electrode leads for the Restore neurostimulator system.

21 Mar 2016

LEO Pharma announces scientific approval of Enstilar for treatment of people living with psoriasis in EU

LEO Pharma today announced that it received scientific approval of Enstilar (calcipotriol/betamethasone dipropionate 50 micrograms/g / 0,5 mg/g) for the treatment of psoriasis vulgaris in patients 18 years of age or older.

21 Mar 2016

Women taking birth control pill less likely to suffer serious knee injuries

Researchers from The University of Texas Medical Branch at Galveston have found that women who take the birth control pill, which lessen and stabilize estrogen levels, were less likely to suffer serious knee injuries. The findings are currently available in Medicine & Science in Sports & Exercise, the official journal of the American College of Sports Medicine.

21 Mar 2016

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Baricitinib drug shows significant success in treatment of rheumatoid arthritis

BSR report outlines plans to help patients make informed choices about their treatment

Researchers explore four potential treatments for Lyme disease

TSRI study shows hollowed-out version of CPMV could be effective in human therapies

High out-of-pocket costs linked to lower use of specialty drugs

Oral administration of cyclotide may improve symptoms of multiple sclerosis

Scientists identify two enzymes that appear to play role in metabolism, inflammation

Novel way of hitting prostate cancer

Engineered HIV vaccine protein may prevent HIV infection

TSRI scientists develop new process to synthesize naturally occurring compound phorbol

Cinqair (reslizumab) approved for treatment of severe asthma

Researchers use DNA sequencing technology to identify gene variants that affect susceptibility to SLE

St. Luke’s surgeon first in world to implant Medtronic’s new, MRI-compatible neurostimulator system

LEO Pharma announces scientific approval of Enstilar for treatment of people living with psoriasis in EU

Women taking birth control pill less likely to suffer serious knee injuries

Older types of arthritis medicine appear to be dangerous for the heart

Psoriasis patients experience widespread bone loss

Global research links genes to five common, hard-to-treat inflammatory diseases

IUPUI researchers examine pain experience, pain management among Hispanic Americans

Combination drug therapy may stop KRAS-mediated lung adenocarcinoma

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

How microRNA is transforming science: From discovery to diagnostics

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

How microRNA is transforming science: From discovery to diagnostics

Newsletters you may be interested in